Friday, 23 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
China's NHC Unveils 2025 Healthcare Reforms to Tackle Procurement and Service Irregularities
Policy / Regulatory

China’s NHC Unveils 2025 Healthcare Reforms to Tackle Procurement and Service Irregularities

June 16, 2025
Thermo Fisher Mulls $4B Diagnostic Business Sale Amid Healthcare Sector Turbulence
CompanyDeals

Thermo Fisher Mulls $4B Diagnostic Business Sale Amid Healthcare Sector Turbulence

June 16, 2025
Changchun High-Tech Subsidiary Gains NMPA Approval for CINV Drug Trial
CompanyDrug

Changchun High-Tech Subsidiary Gains NMPA Approval for CINV Drug Trial

June 16, 2025
Novo Nordisk Advances Amycretin for Weight Management in Phase III Trials
CompanyDrug

Novo Nordisk Advances Amycretin for Weight Management in Phase III Trials

June 16, 2025
FDA OKs MSD's Keytruda for Perioperative Head and Neck Cancer Treatment With PD-L1 Expression
CompanyDrug

FDA OKs MSD’s Keytruda for Perioperative Head and Neck Cancer Treatment With PD-L1 Expression

June 16, 2025
GSK Seeks EMA Approval to Expand RSV Vaccine Arexvy Use to Adults Aged 18+
CompanyDrug

GSK Seeks EMA Approval to Expand RSV Vaccine Arexvy Use to Adults Aged 18+

June 16, 2025
UCB Announces Investment in U.S. Biologics Production Facility
Company

UCB Announces Investment in U.S. Biologics Production Facility

June 16, 2025
Gene Solutions Partners with Shenzhen USK Bio to Advance Precision Oncology in Southern China
CompanyDeals

Gene Solutions Partners with Shenzhen USK Bio to Advance Precision Oncology in Southern China

June 16, 2025
MRI and Astellas Alliance to Boost Japanese Drug Discovery Startups
CompanyDeals

MRI and Astellas Alliance to Boost Japanese Drug Discovery Startups

June 16, 2025
MSD Wins NMPA Approval for Keytruda-Lenvima Combo in Hepatocellular Carcinoma
CompanyDrug

MSD Wins NMPA Approval for Keytruda-Lenvima Combo in Hepatocellular Carcinoma

June 16, 2025
Xuanzhu Biopharma Files for Hong Kong IPO to Advance Innovative Drug Pipeline
CompanyDeals

Xuanzhu Biopharma Files for Hong Kong IPO to Advance Innovative Drug Pipeline

June 16, 2025
Roche Imposes New Dosing Restrictions on Elevidys for Non-Ambulatory DMD Patients
CompanyDrug

Roche Imposes New Dosing Restrictions on Elevidys for Non-Ambulatory DMD Patients

June 16, 2025
1 2 … 13 14 15 16 17 … 27 28
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up